Related Experiment Video
Updated: Aug 30, 2025
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
Development and Validation of a Simple Model to Predict the Risk of Nonmelanoma Skin Cancer on Screening Total Body
Rebecca I Hartman1, Yun Xue2, Ryan Karmouta3
1Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
A new model using cancer history, age, and skin phototype (CAP) accurately predicts nonmelanoma skin cancer (NMSC) risk. This tool aids dermatologists in selecting patients for skin cancer screening examinations.
Area of Science:
- Dermatology
- Epidemiology
- Oncology
Background:
- Population-level guidelines for skin cancer screening are lacking, leading to inconsistent patient selection.
- Screening total body skin examinations (TBSE) are crucial for early detection of nonmelanoma skin cancer (NMSC).
Purpose of the Study:
- To develop a simple, predictive model for NMSC risk assessment during screening TBSE.
- To create an easy-to-use scoring system for clinical decision-making in NMSC screening.
Main Methods:
- An epidemiologic assessment utilized data from a prospective, international, multicenter study.
- A multivariable model was generated using predictors of NMSC and converted into a point-based scoring system.
- Model performance was validated using a separate dataset from two US healthcare institutions.
Main Results:
- The study included 8,501 patients.
- Key predictors of NMSC identified were: history of NMSC, age, and skin phototype.
- The developed model demonstrated high predictive discrimination (AUC = 0.82).
Conclusions:
- A three-variable model, CAP (cancer history, age, phototype), accurately predicts NMSC risk for screening TBSE.
- This CAP tool can enhance clinical decision-making and improve the yield of screening TBSE in dermatology.
More Related Videos
11:02The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
Published on: August 3, 2011
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024